Chemotherapies are extremely toxic and the can interfere with our immune systems, the systems that help us fight off cancer in the first place.  Centrose is developing non-toxic targeted therapies that work with our immune system, not against it.

Centrose develops targeted therapies that treat diseased cells while leaving healthy cells alone. Our therapies are called EDCs. EDCs are manufactured by attaching highly evolved small molecules to specific antibodies. These antibodies bind cell surface proteins on diseased cells. The antibodies allow for direct delivery of the drug to diseased cells. Once EDCs attach to cells, the cells are programmed to stop growing, stop releasing inflammatory proteins and mark themselves for immune system help.

The most advanced therapeutic platform to date, EDCs represent a new paradigm in drug safety and efficacy.